ECSP13012977A - Composiciones y métodos para separar, caracterizar y administrar selenoglicoproteínas solubles - Google Patents

Composiciones y métodos para separar, caracterizar y administrar selenoglicoproteínas solubles

Info

Publication number
ECSP13012977A
ECSP13012977A ECSP13012977A ECSP13012977A EC SP13012977 A ECSP13012977 A EC SP13012977A EC SP13012977 A ECSP13012977 A EC SP13012977A EC SP13012977 A ECSP13012977 A EC SP13012977A
Authority
EC
Ecuador
Prior art keywords
methods
soluble
compositions
selenoglyproteins
characterize
Prior art date
Application number
Other languages
English (en)
Inventor
Stefan Kwiatkowski
Ronan Power
Clayton Matney
Paiman P Ghoroghchian
Eric M Ostertag
Original Assignee
Alltech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alltech Inc filed Critical Alltech Inc
Publication of ECSP13012977A publication Critical patent/ECSP13012977A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1273—Polymersomes; Liposomes with polymerisable or polymerised bilayer-forming substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

La invención se relaciona con composiciones de selenio solubles y métodos de producción, separación y purificación de las mismas. Particularmente la presente invención proporciona métodos para preparar selenoglicoproteínas solubles en agua (por ejemplo, a través de extracción de selenoglicoproteínas de levadura enriquecida con selenio), métodos para suplementar una composición deficiente en selenio a través de la combinación de selenoglicoproteínas solubles en agua con la composición deficiente en selenio, composiciones que comprenden selenoglicoproteínas solubles en agua y métodos para administrar la misma.
ECSP13012977 2011-03-18 2013-10-17 Composiciones y métodos para separar, caracterizar y administrar selenoglicoproteínas solubles ECSP13012977A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13/051,646 US8263752B2 (en) 2010-03-18 2011-03-18 Methods for separating soluble selenoglycoproteins

Publications (1)

Publication Number Publication Date
ECSP13012977A true ECSP13012977A (es) 2013-11-29

Family

ID=44911992

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP13012977 ECSP13012977A (es) 2011-03-18 2013-10-17 Composiciones y métodos para separar, caracterizar y administrar selenoglicoproteínas solubles

Country Status (22)

Country Link
US (1) US8263752B2 (es)
EP (1) EP2686416B1 (es)
JP (1) JP2014514277A (es)
KR (1) KR101571231B1 (es)
CN (1) CN103443265B (es)
AU (1) AU2011362979B2 (es)
CA (1) CA2828477C (es)
CL (1) CL2013002639A1 (es)
DK (1) DK2686416T3 (es)
EA (1) EA030339B1 (es)
EC (1) ECSP13012977A (es)
ES (1) ES2709623T3 (es)
IL (1) IL228085A0 (es)
MX (1) MX345862B (es)
MY (1) MY180517A (es)
NZ (1) NZ614634A (es)
PH (1) PH12013501919A1 (es)
PT (1) PT2686416T (es)
SG (1) SG193358A1 (es)
UA (1) UA114082C2 (es)
WO (1) WO2012128786A2 (es)
ZA (1) ZA201306419B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101632928B1 (ko) * 2014-06-07 2016-06-24 김우열 나노리포좀 액상 단미사료 제조방법 및 이에 제조된 액상 단미사료
KR101705320B1 (ko) * 2015-01-05 2017-02-10 주식회사이-글벳 생균수가 증가된 배지조성에 의한 발효사료의 제조방법 및 그 발효사료
CN107459563B (zh) * 2017-08-11 2020-06-19 广西壮族自治区农业科学院农业资源与环境研究所 一种提取硒蛋白过程中的沉淀工艺
CN112129864B (zh) * 2020-09-24 2022-04-01 江南大学 一种富硒植物干粉中硒形态测定的方法
CN116409758A (zh) * 2021-12-29 2023-07-11 中国农业科学院都市农业研究所 一种纳米硒的制备方法
CN119220615B (zh) * 2024-11-11 2025-03-21 山东玖瑞农业集团有限公司 一种多硒代半胱氨酸硒蛋白p有机硒制剂

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57174098A (en) * 1981-04-17 1982-10-26 Sapporo Breweries Ltd Preparation of physiologically active proteinic polysaccharide seps containing selenium
US5221545A (en) 1992-03-09 1993-06-22 Abbott Laboratories Method of providing selenium in a nutritional product
JPH07300409A (ja) * 1994-04-28 1995-11-14 Ichimaru Pharcos Co Ltd セレン含有酵母の抽出エキスを含有する化粧料組成物
ATE246212T1 (de) 1995-05-26 2003-08-15 Igen Inc Molekular geprägten perl polymere und stabilisierte suspensionspolymerisation von diesen in perfluorkohlstoff flussigkeiten
US6197295B1 (en) 1996-09-25 2001-03-06 Viva America Marketing Corporation Dietary supplementation with, and methods for administration of yeast-derived selenium product
US6835394B1 (en) 1999-12-14 2004-12-28 The Trustees Of The University Of Pennsylvania Polymersomes and related encapsulating membranes
WO2003017987A1 (en) 2001-08-31 2003-03-06 Mcgill University Biodegradable polymeric nanocapsules and uses thereof
DK174835B1 (da) * 2002-03-15 2003-12-15 Pharma Nord Aps Selengærprodukt, fremgangsmåde til fremstilling af et selengærprodukt samt anvendelse af produktet til fremstilling af en fødevare, et kosttilskud, eller et lægemiddel
US6911550B2 (en) 2003-02-21 2005-06-28 Zinpro Corporation Derivatives of seleno-amino acids with improved bioavailability and method for their preparation
US7682603B2 (en) 2003-07-25 2010-03-23 The Trustees Of The University Of Pennsylvania Polymersomes incorporating highly emissive probes
US20050069594A1 (en) 2003-08-11 2005-03-31 Jan Lubinski Pharmaceutical compositions and methods for the prevention of breast and ovarian cancer
MX2007013725A (es) 2005-05-05 2008-04-09 Sensient Flavors Inc Produccion de beta-glucanos y mananos.
CA2624174A1 (en) * 2005-09-28 2007-04-05 The Trustees Of The University Of Pennsylvania Self-assembled biodegradable polymersomes
US20070077238A1 (en) * 2005-10-04 2007-04-05 Teo Alex Y Production of organic and inorganic selenium compounds by lactic acid bacteria
CN102764279B (zh) * 2005-10-14 2015-04-01 全面技术公司 改变细胞功能的方法和组合物
CA2650309C (en) 2006-04-24 2014-08-19 Alltech, Inc. Selenium-containing compositions and use of the same
JP2008260823A (ja) * 2007-04-11 2008-10-30 Univ Of Fukui 亜セレン酸化多糖類およびその製造方法
CN101869183B (zh) * 2010-05-28 2013-03-20 广州立达尔生物科技股份有限公司 一种富硒酵母水解物及其生产方法

Also Published As

Publication number Publication date
EP2686416A4 (en) 2014-11-12
PT2686416T (pt) 2019-02-06
NZ614634A (en) 2015-08-28
IL228085A0 (en) 2013-09-30
WO2012128786A3 (en) 2013-07-25
DK2686416T3 (en) 2019-03-04
JP2014514277A (ja) 2014-06-19
AU2011362979A1 (en) 2013-09-12
MX2013010684A (es) 2013-10-07
EA030339B1 (ru) 2018-07-31
EP2686416B1 (en) 2018-11-07
US20110280948A1 (en) 2011-11-17
MY180517A (en) 2020-12-01
SG193358A1 (en) 2013-10-30
ZA201306419B (en) 2015-03-25
CL2013002639A1 (es) 2014-04-11
EA201391340A1 (ru) 2014-07-30
CN103443265A (zh) 2013-12-11
MX345862B (es) 2017-02-20
CA2828477C (en) 2017-02-21
ES2709623T3 (es) 2019-04-17
UA114082C2 (xx) 2017-04-25
CA2828477A1 (en) 2012-09-27
CN103443265B (zh) 2016-06-29
PH12013501919A1 (en) 2013-11-25
KR20130127525A (ko) 2013-11-22
AU2011362979B2 (en) 2015-09-03
US8263752B2 (en) 2012-09-11
WO2012128786A2 (en) 2012-09-27
KR101571231B1 (ko) 2015-11-23
EP2686416A2 (en) 2014-01-22
BR112013023440A2 (pt) 2021-10-05

Similar Documents

Publication Publication Date Title
BR112014024903A2 (pt) anticorpos biespecíficos contra tweak humanao e il17 humana e seus usos
GB201118656D0 (en) New compounds
WO2012129341A3 (en) Disease detection in plants
UA110054C2 (uk) Розгалужені похідні 3-фенілпропіонової кислоти і їх застосування
IN2015KN00262A (es)
UY33735A (es) Compuestos antivirales
MX362512B (es) Composiciones purificadas de celulas madre mesenquimales y metodos para purificar composiciones de celulas madre mesenquimales.
MX349004B (es) Nuevos compuestos.
ECSP13012977A (es) Composiciones y métodos para separar, caracterizar y administrar selenoglicoproteínas solubles
UA116999C2 (uk) Виділене антитіло до гемаглютиніну та фармацевтична композиція, що його містить
TN2014000185A1 (en) Polyethylene glycol based prodrug of adrenomedullin and use thereof
BR112015000229A2 (pt) formulações aquosas estáveis de etanercept
WO2012037562A3 (en) Pharmaceutical and nutraceutical compositions of abscisic acid
MX2014010433A (es) Nueva forma cristalina de sulfato de sitagliptina.
WO2014203275A3 (en) An improved process for the preparation of apixaban and intermediates thereof
HK1201067A1 (en) Sialic acid analogs
IN2015DN04074A (es)
IN2014DN03010A (es)
BR112013026868A2 (pt) intermediário para a síntese de caspofungina e método para o seu preparo
WO2013083226A8 (de) Porenarmes, wasserfreies natriumcarbonat
WO2014122671A3 (en) Solid oral compositions of saxagliptin
GT201200066A (es) Nuevos derivados dihidro-oxazolobenzodiazepinonas, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
WO2013054364A3 (en) Novel salts of sitagliptin, process for the preparation and pharmaceutical composition thereof
WO2013064326A3 (de) Arjunolsäure zur erhöhung der sebumproduktion
MX340219B (es) Metodo para producir eteres de enol ciclicos.